| P50 | author | John P. Greenwood | Q47067287 |
| | Sven Plein | Q47067377 |
| | Tarique Al Musa | Q53844400 |
| P2860 | cites work | Cardiac systolic rotation and contraction before and after valve replacement for aortic stenosis: a myocardial tagging study using MR imaging | Q77800504 |
| | Reduced aortic elasticity and dilatation are associated with aortic regurgitation and left ventricular hypertrophy in nonstenotic bicuspid aortic valve patients | Q80157942 |
| | Valvular heart disease in the community: a European experience | Q81538144 |
| | Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis | Q83241225 |
| | Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology | Q83277788 |
| | Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis | Q84342706 |
| | Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes | Q85662372 |
| | Transcatheter aortic valve implantation: a durable treatment option in aortic stenosis? | Q87169790 |
| | 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q87410706 |
| | Myocardial damage after TAVR assessed with CMR: a new piece in a puzzle? | Q87440860 |
| | Comparison of two- and three-dimensional transthoracic echocardiography to cardiac magnetic resonance imaging for assessment of paravalvular regurgitation after transcatheter aortic valve implantation | Q87896264 |
| | 4D flow cardiovascular magnetic resonance consensus statement | Q26800281 |
| | Risk Stratification in Patients With Aortic Stenosis Using Novel Imaging Approaches | Q26801333 |
| | Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme | Q28081869 |
| | Homograft replacement of the aortic valve | Q28203812 |
| | Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description | Q28216985 |
| | Quantitative assessment of paravalvular regurgitation following transcatheter aortic valve replacement | Q30412154 |
| | The role of cardiac magnetic resonance in valvular heart disease | Q30449017 |
| | Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study | Q30453765 |
| | Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry | Q34054341 |
| | Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery | Q34144699 |
| | High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis | Q34145900 |
| | Time-resolved three-dimensional phase-contrast MRI. | Q34185878 |
| | Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy | Q34392406 |
| | The global burden of aortic stenosis | Q34420441 |
| | Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromes | Q34422721 |
| | Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? | Q34510314 |
| | Assessment of left ventricular mass by cardiovascular magnetic resonance. | Q34565689 |
| | Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience | Q34616121 |
| | Assessment of myocardial fibrosis with cardiovascular magnetic resonance | Q34846884 |
| | Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation | Q35203773 |
| | Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis | Q35771997 |
| | Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. | Q35836894 |
| | The quantification of infarct size | Q35920417 |
| | Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement | Q36051837 |
| | Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies | Q36098649 |
| | Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. | Q36186565 |
| | Adiposity of the heart, revisited | Q36439598 |
| | Blood flow characteristics in the ascending aorta after TAVI compared to surgical aortic valve replacement | Q36950304 |
| | Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study | Q37105484 |
| | Blood flow characteristics in the ascending aorta after aortic valve replacement--a pilot study using 4D-flow MRI. | Q37398690 |
| | Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations | Q37448642 |
| | Transcatheter aortic valve insertion (TAVI): a review. | Q37504871 |
| | 4D flow imaging with MRI | Q37717699 |
| | Aortic stiffness: current understanding and future directions | Q37859936 |
| | Heart valve disease: investigation by cardiovascular magnetic resonance | Q37977134 |
| | Lipid metabolism and toxicity in the heart | Q38017379 |
| | Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. | Q38059108 |
| | TAVI: from home-made prosthesis to global interventional phenomenon | Q38059109 |
| | Degenerative calcific aortic stenosis: a natural history | Q38059115 |
| | Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge | Q38075865 |
| | Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature | Q38090308 |
| | Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications | Q38166733 |
| | Markers of left ventricular decompensation in aortic stenosis. | Q38215381 |
| | Epidemiology of acquired valvular heart disease | Q38225416 |
| | Advances in the understanding of the pathophysiology and management of aortic stenosis: role of novel imaging techniques | Q38228582 |
| | Cardiac MRI: a central prognostic tool in myocardial fibrosis | Q38263089 |
| | Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. | Q38484008 |
| | Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. | Q38522479 |
| | Guidelines on the management of valvular heart disease (version 2012). | Q40276570 |
| | Sex Differences in Aortic Stenosis and Outcome Following Surgical and Transcatheter Aortic Valve Replacement | Q41062284 |
| | 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement | Q41685192 |
| | Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. | Q42787147 |
| | 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial | Q44143856 |
| | The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk | Q44510760 |
| | The evolving epidemiology of valvular aortic stenosis. the Tromsø study | Q44739169 |
| | Reproducibility of flow and wall shear stress analysis using flow-sensitive four-dimensional MRI. | Q44771827 |
| | Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis | Q44816605 |
| | MRI phase contrast velocity and flow errors in turbulent stenotic jets | Q47612223 |
| | Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement: effect on health-related quality of life | Q48047250 |
| | Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes | Q48447195 |
| | Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. | Q50569819 |
| | Regional left ventricular function after transapical vs. transfemoral transcatheter aortic valve implantation analysed by cardiac magnetic resonance feature tracking. | Q50616192 |
| | Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 Tesla: a comparison of feature-tracking and tagging in patients with aortic stenosis. | Q50619868 |
| | 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. | Q51042602 |
| | Reproducibility of myocardial strain and left ventricular twist measured using complementary spatial modulation of magnetization. | Q51167436 |
| | Percutaneous aortic valve implantation retrograde from the femoral artery. | Q51275862 |
| | The changing course of aortic valve disease in Scotland: temporal trends in hospitalizations and mortality and prognostic importance of aortic stenosis. | Q51299741 |
| | Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates. | Q51573932 |
| | In vivo noninvasive 4D pressure difference mapping in the human aorta: phantom comparison and application in healthy volunteers and patients. | Q51585723 |
| | On MRI turbulence quantification. | Q51820506 |
| | Physiologic compensation is supranormal in compensated aortic stenosis: does it return to normal after aortic valve replacement or is it blunted by coexistent coronary artery disease? An intramyocardial magnetic resonance imaging study. | Q51840931 |
| | Impairment of coronary flow reserve in aortic stenosis. | Q51865001 |
| | Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study. | Q52838753 |
| | Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. | Q53060223 |
| | Next-generation transcatheter aortic valve replacement: evolution of a revolution. | Q53433557 |
| | Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. | Q53650374 |
| | Detection of myocardial injury by CMR after transcatheter aortic valve replacement. | Q55072693 |
| | Left Ventricular Mass | Q57243092 |
| | Left Ventricular Hypertrophy With Strain and Aortic Stenosis | Q57721102 |
| | Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement | Q57741458 |
| | Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? | Q57780007 |
| | Determinants and Functional Significance of Myocardial Perfusion Reserve in Severe Aortic Stenosis | Q61650959 |
| | Burden of valvular heart diseases: a population-based study | Q61663367 |
| | Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis | Q61727660 |
| | Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement | Q69295549 |
| | Aortic stenosis | Q69881520 |
| | Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms | Q73035986 |
| | Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts | Q73120097 |
| | Right and left ventricular volume measurements in an animal heart model in vitro: first experiences with cardiac MRI at 1.0 T | Q73655778 |
| | Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry | Q73936884 |
| | The surgical correction of aortic regurgitation preliminary report | Q74039076 |
| | Homologous aortic-valve-segment transplants as surgical treatment for aortic and mitral insufficiency | Q74238253 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aorta | Q101004 |
| | cardiac surgery | Q235007 |
| P304 | page(s) | 259-273 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Quantitative imaging in medicine and surgery | Q26841874 |
| P1476 | title | The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement | |
| P478 | volume | 6 | |